About
Serica

• Technology Overview
• History
• Strategy
  • Central Tenet
  • Approach
• Leadership

Strategy of Serica

Improve the quality and outcome of connective tissue repair

Disease, trauma, and aging have created unmet clinical needs in connective tissue repair. Serica was created to lead the development and commercialization of medical device solutions which restore a patient’s own tissue to its original functionality.

Across all platforms and across all markets, Serica has one commitment:

To improve the quality of patient care, to increase surgical efficiency, and to reduce healthcare costs through significant advancement in connective tissue repair.

Central Tenet

Serica’s first responsibility is to the patients who receive its products. We seek to develop enabling technologies which ensure our patients’ return to active and rewarding lifestyles. Our multi-disciplinary team intends to be the leader in developing advanced medical device, silk protein scaffold products for tissue repair.

The company is passionate about integrating engineering, medicine, and the basic sciences to create novel solutions that have the potential to dramatically improve current standards of care in several medical specialties.

Approach

Serica will continue to develop its proprietary product portfolio and strong commercial presence in the company’s two core markets:

• Orthopaedic and Sports Medicine
• Aesthetic and Plastic Reconstructive Surgery

The company has leveraged its key resources and unique platform with truly differentiated features and benefits to create a sustainable competitive advantage.

Serica’s proprietary position and knowledge in silk-based biomaterials supports the company’s continued achievement of critical milestones in new product development.

Built on the Seri™ and SeriGel™ biomaterial platforms, Serica’s silk protein-based products are being developed to offer a significant value proposition to both patients and customers by:

• Providing to patients a complete and faster return to full functionality by improving efficacy of repairs and by decreasing rehabilitation periods.
• Increasing surgical efficiency by providing an integrated systems solution approach from custom-designed scaffold to surgical instrumentation and device fixation.
• Reducing healthcare costs by improving the quality of patient care.

Competitive cost structures result from Serica’s ability to internally manufacture its products from raw materials to finished goods. As a result, Serica is well positioned to successfully distribute its products—through its own marketing and sales resources and strategic alliances—worldwide.